Literature DB >> 24827057

Lack of association between azithromycin and death from cardiovascular causes.

Christine M Khosropour1, Jeffrey D Capizzi, Sean D Schafer, James B Kent, Julia C Dombrowski, Matthew R Golden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24827057      PMCID： PMC4091032          DOI： 10.1056/NEJMc1401831

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  Sexually transmitted diseases treatment guidelines, 2010.

Authors:  Kimberly A Workowski; Stuart Berman
Journal:  MMWR Recomm Rep       Date:  2010-12-17

3.  Use of azithromycin and death from cardiovascular causes.

Authors:  Henrik Svanström; Björn Pasternak; Anders Hviid
Journal:  N Engl J Med       Date:  2013-05-02       Impact factor: 91.245
  3 in total
  7 in total

1.  Duration and life-stage of antibiotic use and risk of cardiovascular events in women.

Authors:  Yoriko Heianza; Yan Zheng; Wenjie Ma; Eric B Rimm; Christine M Albert; Frank B Hu; Kathryn M Rexrode; JoAnn E Manson; Lu Qi
Journal:  Eur Heart J       Date:  2019-12-14       Impact factor: 29.983

2.  Diagnosis and Management of Uncomplicated Chlamydia trachomatis Infections in Adolescents and Adults: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.

Authors:  William M Geisler; Jane S Hocking; Toni Darville; Byron E Batteiger; Robert C Brunham
Journal:  Clin Infect Dis       Date:  2022-04-13       Impact factor: 9.079

Review 3.  Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report.

Authors:  Mark S Riddle; Bradley A Connor; Nicholas J Beeching; Herbert L DuPont; Davidson H Hamer; Phyllis Kozarsky; Michael Libman; Robert Steffen; David Taylor; David R Tribble; Jordi Vila; Philipp Zanger; Charles D Ericsson
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

4.  Use of Antibiotics in Pediatrics: 8-Years Survey in Italian Hospitals.

Authors:  Elena Buccellato; Mauro Melis; Chiara Biagi; Monia Donati; Domenico Motola; Alberto Vaccheri
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

Review 5.  Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.

Authors:  Wilmore C Webley; David L Hahn
Journal:  Respir Res       Date:  2017-05-19

6.  Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice.

Authors:  Young Choi; Hong-Seok Lim; Dahee Chung; Jung-Gu Choi; Dukyong Yoon
Journal:  Biomed Res Int       Date:  2018-10-14       Impact factor: 3.411

7.  An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine.

Authors:  Raman L Mitra; Steven A Greenstein; Laurence M Epstein
Journal:  HeartRhythm Case Rep       Date:  2020-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.